tert-Butyl (R)-(1-hydroxypentan-2-yl)carbamate

Catalog No. :
ACBHQO934
CAS No. :
116611-57-5
Molecular Formula :
C10H21NO3
Molecular Weight :
203.28

IUPAC Name:tert-butyl (R)-(1-hydroxypentan-2-yl)carbamate

tert-Butyl (R)-(1-hydroxypentan-2-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$2172.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (R)-(1-hydroxypentan-2-yl)carbamate
IUPAC Nametert-butyl (R)-(1-hydroxypentan-2-yl)carbamate
MDL No.MFCD22665918
Molecular FormulaC10H21NO3
Molecular Weight203.28
SMILESCCC[C@H](CO)NC(=O)OC(C)(C)C
InChI KeyGCBVZHIDLDHLOF-MRVPVSSYSA-N
Synonymtert-butyl [(1S)-1-(hydroxymethyl)butyl]carbamate;(R)-[1-(Hydroxymethyl)butyl]carbamic acid 1,1-dimethylethyl ester;[(R)-1-(Hydroxymethyl)butyl]carbamic acid tert-butyl ester;N-[(1R)-1-(Hydroxymethyl)butyl]carbamic acid 1,1-dimethylethyl ester;CarbaMic acid, N-[(1R)-1-(hydroxyMethyl)butyl]-, 1,1-diMethylethyl ester;(R)-2-(Boc-amino)-1-pentanol;(R)-tert-butyl (1-hydroxypentan-2-yl)carbamate;N-Boc-D-Norvalinol
CAS No.116611-57-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACBHQO934 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACECTN731 route compound structure diagram
    ACECTN73180696-30-6 In Stock
  4. Then
  5. ACBHQO934 route product structure diagram
    ACBHQO934116611-57-5
Inquiry

2. ACBHQO934 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMILR435 route compound structure diagram
    ACMILR43557521-85-4 In Stock
  2. Then
  3. ACBHQO934 route product structure diagram
    ACBHQO934116611-57-5
Inquiry

Comments (0)